Ugur Sahin Selected Research

Ugur Sahin Research Topics

Disease

128	Neoplasms (Cancer) 05/2024 - 02/2002
20	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2006
15	Infections 12/2023 - 09/2004
13	Melanoma (Melanoma, Malignant) 01/2022 - 02/2002
10	COVID-19 02/2023 - 10/2020
8	Testicular Neoplasms (Testicular Cancer) 01/2022 - 07/2003
7	Communicable Diseases (Infectious Diseases) 06/2024 - 04/2006
7	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 11/2018
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2011
6	Inflammation (Inflammations) 12/2023 - 07/2014
6	Adenocarcinoma 08/2023 - 04/2006
4	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 02/2014
4	Breakthrough Infections 01/2023 - 01/2022
3	Glioma (Gliomas) 11/2022 - 08/2014
3	Hypoxia (Hypoxemia) 08/2022 - 11/2002
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 05/2008
3	Carcinoma (Carcinomatosis) 01/2019 - 11/2014
3	Virus Diseases (Viral Diseases) 10/2018 - 09/2004
3	Thrombosis (Thrombus) 01/2018 - 11/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2014 - 05/2006
2	Body Weight (Weight, Body) 01/2023 - 06/2018
2	Hodgkin Disease (Hodgkin's Disease) 10/2022 - 12/2002
2	Lymphoma (Lymphomas) 01/2022 - 12/2019
2	Experimental Melanoma 01/2021 - 12/2013
2	Vesicular Stomatitis 11/2020 - 09/2004
2	Choriocarcinoma 05/2020 - 01/2018
2	Human Influenza (Influenza) 01/2020 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 09/2019 - 06/2011
2	Leukemia 06/2018 - 07/2003
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018 - 01/2015

Drug/Important Bio-Agent (IBA)

46	AntigensIBA 12/2023 - 05/2002
42	VaccinesIBA 12/2023 - 07/2003
37	RNA (Ribonucleic Acid)IBA 06/2024 - 12/2006
30	Messenger RNA (mRNA)IBA 06/2024 - 08/2006
21	Proteins (Proteins, Gene)FDA Link 06/2024 - 07/2003
20	mRNA VaccinesIBA 12/2023 - 10/2011
15	EpitopesIBA 01/2022 - 02/2002
12	Peptides (Polypeptides)IBA 01/2023 - 02/2002
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2014
10	Neoplasm Antigens (Tumor Antigens)IBA 06/2019 - 07/2003
8	AntibodiesIBA 09/2021 - 05/2002
8	Cancer VaccinesIBA 01/2020 - 05/2006
8	AutoantibodiesIBA 11/2015 - 10/2003
6	Monoclonal AntibodiesIBA 03/2024 - 05/2008
6	zolbetuximabIBA 08/2023 - 02/2014
5	ClaudinsIBA 05/2024 - 02/2014
5	BNT162 VaccineIBA 12/2022 - 10/2020
5	Protein Isoforms (Isoforms)IBA 01/2016 - 11/2002
5	Complementary DNA (cDNA)IBA 11/2015 - 12/2003
4	N-(2-cyanoethylene)urea (BA 1)IBA 12/2022 - 01/2022
4	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2016
4	claudin 6IBA 01/2020 - 11/2014
4	Estrogen ReceptorsIBA 07/2019 - 03/2013
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 11/2015
4	ParaffinIBA 10/2018 - 05/2012
4	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 09/2004
3	LipidsIBA 05/2024 - 10/2015
3	Lipid NanoparticlesIBA 08/2023 - 10/2015
3	Glycoproteins (Glycoprotein)IBA 12/2022 - 11/2020
3	N-methyl-valyl-amiclenomycin (BA 2)IBA 12/2022 - 01/2022
3	Chimeric Antigen ReceptorsIBA 11/2022 - 01/2020
3	CytokinesIBA 11/2022 - 10/2020
3	LigandsIBA 05/2020 - 01/2018
3	human ERBB2 proteinIBA 07/2019 - 11/2017
3	Phenobarbital (Luminal)FDA Link 07/2019 - 01/2016
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 01/2016
3	Formaldehyde (Formol)FDA Link 10/2018 - 01/2016
3	Synthetic Vaccines (Recombinant Vaccines)IBA 12/2017 - 04/2006
2	Interleukin-2 (IL2)IBA 03/2024 - 08/2023
2	Histocompatibility Antigens Class IIBA 03/2024 - 01/2018
2	NucleotidesIBA 01/2023 - 01/2019
2	Nucleic AcidsIBA 01/2023 - 01/2015
2	Neutralizing AntibodiesIBA 12/2022 - 01/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 01/2020
2	Gemcitabine FDA Link 10/2022 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 09/2018
2	EnzymesIBA 01/2022 - 11/2002
2	InterferonsIBA 09/2021 - 09/2020
2	Immunoglobulin G (IgG)IBA 10/2020 - 01/2005
2	Hemagglutinins (Hemagglutinin)IBA 01/2020 - 01/2018
2	cyclopropapyrroloindoleIBA 01/2020 - 01/2020
2	Fibronectins (Fibronectin)IBA 01/2020 - 04/2006
2	ProteomeIBA 01/2019 - 11/2018
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 01/2011
2	Docetaxel (Taxotere)FDA Link 01/2018 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 12/2017
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018 - 01/2016
2	CarcinogensIBA 12/2017 - 06/2011
2	Trace Elements (Biometals)IBA 12/2017 - 10/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2017 - 03/2013
2	Bispecific AntibodiesIBA 10/2017 - 07/2017

Therapy/Procedure

49	Immunotherapy 05/2024 - 02/2002
38	Therapeutics 08/2023 - 04/2006
11	Drug Therapy (Chemotherapy) 10/2022 - 04/2006
8	Hematopoietic Stem Cell Transplantation 01/2022 - 08/2016
4	Stem Cell Transplantation 01/2023 - 09/2018
3	Radiotherapy 03/2024 - 01/2020
2	Intravenous Injections 01/2021 - 10/2015
2	Neoadjuvant Therapy 09/2018 - 05/2012
2	Adjuvant Chemotherapy 09/2018 - 01/2018